{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:34:50Z","timestamp":1794429290400,"version":"4.9.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["MetaboHUB-ANR-11-INBS-0010"],"award-info":[{"award-number":["MetaboHUB-ANR-11-INBS-0010"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Society Francaise de Dermatologie, Paris, France Fondation Avenir, Paris, France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Endotypes are characterized by the immunological, inflammatory, metabolic, and remodelling pathways that explain the mechanisms underlying the clinical presentation (phenotype) of a disease. Recessive dystrophic epidermolysis bullosa (RDEB) is a severe blistering disease caused by\n                    <jats:italic>COL7A1<\/jats:italic>\n                    pathogenic variants. Although underscored by animal studies, the endotypes of human RDEB are poorly understood. To fill this gap, we apply systems immunology approaches using single-cell high-dimensional techniques to capture the signature of peripheral immune cells and the diversity of metabolic profiles in RDEB adults, sampled outside of any opportunistic infection and active cancer. Our study, demonstrates the particular inflammation and immunity characteristics of RDEB adults, with activated \/ effector T and dysfunctional natural killer cell signatures, concomitant with an overall pro-inflammatory lipid signature. Artificial intelligence prediction models and principal component analysis stress that RDEB is not solely confined to cutaneous issues but has complex systemic endotypes marked by immune dysregulation and hyperinflammation. By characterising the phenotype-endotype association in RDEB adults, our study lays the groundwork for translational interventions that could by lessening inflammation, alleviate the everlasting suffering of RDEB patients, while awaiting curative genetic therapies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-55934-7","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T12:14:07Z","timestamp":1736856847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-4886","authenticated-orcid":false,"given":"Nell","family":"Hirt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-9978","authenticated-orcid":false,"given":"Enzo","family":"Manchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Delaroque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelien","family":"Corneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-5321","authenticated-orcid":false,"given":"Patrice","family":"Hemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa","family":"Saker-Delye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-David","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5375-738X","authenticated-orcid":false,"given":"Emmanuelle","family":"Bourrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3412-7512","authenticated-orcid":false,"given":"Alain","family":"Hovnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Le Buanec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi","family":"Aoudjit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8889-9759","authenticated-orcid":false,"given":"Hicham","family":"El Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-7836","authenticated-orcid":false,"given":"Nabila","family":"Jabrane-Ferrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-2845","authenticated-orcid":false,"given":"Reem","family":"Al-Daccak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"55934_CR1","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.3390\/ijms22105104","volume":"22","author":"G Tartaglia","year":"2021","unstructured":"Tartaglia, G., Cao, Q., Padron, Z. M. & South, A. P. Impaired wound healing, fibrosis, and cancer: the paradigm of recessive dystrophic epidermolysis bullosa. Int J. Mol. Sci. 22, 5104 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"55934_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.737272","volume":"12","author":"A Nystrom","year":"2021","unstructured":"Nystrom, A., Bruckner-Tuderman, L. & Kiritsi, D. Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers. Front Genet. 12, 737272 (2021).","journal-title":"Front Genet."},{"key":"55934_CR3","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","volume":"112","author":"S Heinonen","year":"1999","unstructured":"Heinonen, S. et al. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J. Cell Sci. 112, 3641\u20133648 (1999).","journal-title":"J. Cell Sci."},{"key":"55934_CR4","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1172\/JCI68127","volume":"123","author":"A Nystrom","year":"2013","unstructured":"Nystrom, A. et al. Collagen VII plays a dual role in wound healing. J. Clin. Invest. 123, 3498\u20133509 (2013).","journal-title":"J. Clin. Invest."},{"key":"55934_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/labinvest.2017.85","volume":"97","author":"BR Webber","year":"2017","unstructured":"Webber, B. R. et al. Rapid generation of Col7a1(-\/-) mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells. Lab Invest. 97, 1218\u20131224 (2017).","journal-title":"Lab Invest."},{"key":"55934_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211505","volume":"14","author":"M Anderson-Crannage","year":"2023","unstructured":"Anderson-Crannage, M. et al. Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin. Front Immunol. 14, 1211505 (2023).","journal-title":"Front Immunol."},{"key":"55934_CR7","doi-asserted-by":"publisher","first-page":"E705","DOI":"10.1073\/pnas.1709111115","volume":"115","author":"A Nystrom","year":"2018","unstructured":"Nystrom, A. et al. Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa. Proc. Natl Acad. Sci. USA 115, E705\u2013E714 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55934_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.15252\/emmm.201505061","volume":"7","author":"A Nystrom","year":"2015","unstructured":"Nystrom, A. et al. Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol. Med 7, 1211\u20131228 (2015).","journal-title":"EMBO Mol. Med"},{"key":"55934_CR9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/ijms17101625","volume":"17","author":"S Esposito","year":"2016","unstructured":"Esposito, S. et al. Autoimmunity and cytokine imbalance in inherited epidermolysis bullosa. Int J. Mol. Sci. 17, 1625 (2016).","journal-title":"Int J. Mol. Sci."},{"key":"55934_CR10","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.jid.2017.07.002","volume":"137","author":"V Alexeev","year":"2017","unstructured":"Alexeev, V. et al. Pro-Inflammatory chemokines and cytokines dominate the blister luid molecfular signature in patients with epidermolysis bullosa and affect leukocyte and stem cell migration. J. Invest Dermatol 137, 2298\u20132308 (2017).","journal-title":"J. Invest Dermatol"},{"key":"55934_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jdermsci.2020.10.009","volume":"100","author":"T Phillips","year":"2020","unstructured":"Phillips, T. et al. Aberrant recruitment of leukocytes defines poor wound healing in patients with recessive dystrophic epidermolysis bullosa. J. Dermatol. Sci. 100, 209\u2013216 (2020).","journal-title":"J. Dermatol. Sci."},{"key":"55934_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71794-1","volume":"10","author":"I Fuentes","year":"2020","unstructured":"Fuentes, I. et al. Cells from discarded dressings differentiate chronic from acute wounds in patients with epidermolysis bullosa. Sci. Rep. 10, 15064 (2020).","journal-title":"Sci. Rep."},{"key":"55934_CR13","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/exd.14411","volume":"30","author":"L Huitema","year":"2021","unstructured":"Huitema, L., Phillips, T., Alexeev, V. & Igoucheva, O. Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa. Exp. Dermatol 30, 1724\u20131733 (2021).","journal-title":"Exp. Dermatol"},{"key":"55934_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/exd.14615","volume":"31","author":"V Alexeev","year":"2022","unstructured":"Alexeev, V. et al. T-cell activation and bacterial infection in skin wounds of recessive dystrophic epidermolysis bullosa patients. Exp. Dermatol. 31, 1431\u20131442 (2022).","journal-title":"Exp. Dermatol."},{"key":"55934_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jaad.2019.11.038","volume":"83","author":"E Rashidghamat","year":"2020","unstructured":"Rashidghamat, E. et al. Phase I\/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. J. Am. Acad. Dermatol. 83, 447\u2013454 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"55934_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.576558","volume":"7","author":"Maseda R","year":"2020","unstructured":"Maseda R et al. Beneficial effect of systemic allogeneic adipose derived mesenchymal cells on the clinical, inflammatory and immunologic status of a patient with recessive dystrophic epidermolysis bullosa: a case report. Front Med. (Lausanne) 7, 576558 (2020).","journal-title":"Front Med. (Lausanne)"},{"key":"55934_CR17","doi-asserted-by":"publisher","first-page":"E151922","DOI":"10.1172\/jci.insight.151922","volume":"6","author":"D Kiritsi","year":"2021","unstructured":"Kiritsi, D. et al. Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa. JCI Insight. 6, E151922 (2021).","journal-title":"JCI Insight."},{"key":"55934_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jdin.2020.12.007","volume":"2","author":"CL Rogers","year":"2021","unstructured":"Rogers, C. L. et al. A comparison study of outcome measures for epidermolysis bullosa: epidermolysis bullosa disease activity and scarring index (EBDASI) and the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB). JAAD Int. 2, 134\u2013152 (2021).","journal-title":"JAAD Int."},{"key":"55934_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/1523-1747.ep12539946","volume":"58","author":"GS Lazarus","year":"1972","unstructured":"Lazarus, G. S. Collagenase and connective tissue metabolism in epidermolysis bullosa. J. Invest. Dermatol. 58, 242\u2013248 (1972).","journal-title":"J. Invest. Dermatol."},{"key":"55934_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/archderm.1992.01680120073006","volume":"128","author":"V Chopra","year":"1992","unstructured":"Chopra, V., Tyring, S. K., Johnson, L. & Fine, J. D. Peripheral blood mononuclear cell subsets in patients with severe inherited forms of epidermolysis bullosa. Arch. Dermatol. 128, 201\u2013209 (1992).","journal-title":"Arch. Dermatol."},{"key":"55934_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/archderm.1989.01670180069008","volume":"125","author":"SK Tyring","year":"1989","unstructured":"Tyring, S. K., Chopra, V., Johnson, L. & Fine, J. D. Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa. Arch. Dermatol. 125, 797\u2013800 (1989).","journal-title":"Arch. Dermatol."},{"key":"55934_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114392","volume":"13","author":"R Bernasconi","year":"2021","unstructured":"Bernasconi, R. et al. Pro-inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang-(1-7). EMBO Mol. Med. 13, e14392 (2021).","journal-title":"EMBO Mol. Med."},{"key":"55934_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666233","volume":"12","author":"R Elaldi","year":"2021","unstructured":"Elaldi, R. et al. High dimensional imaging mass cytometry panel to visualize the tumor immune microenvironment contexture. Front Immunol. 12, 666233 (2021).","journal-title":"Front Immunol."},{"key":"55934_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.imlet.2021.09.009","volume":"240","author":"F Esen","year":"2021","unstructured":"Esen, F., Deniz, G. & Aktas, E. C. PD-1, CTLA-4, LAG-3, and TIGIT: the roles of immune checkpoint receptors on the regulation of human NK cell phenotype and functions. Immunol. Lett. 240, 15\u201323 (2021).","journal-title":"Immunol. Lett."},{"key":"55934_CR25","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.3389\/fimmu.2019.03010","volume":"10","author":"PM Lanuza","year":"2019","unstructured":"Lanuza, P. M. et al. Recalling the biological significance of immune checkpoints on NK cells: a chance to overcome LAG3, PD1, and CTLA4 inhibitory pathways by adoptive NK cell transfer? Front Immunol. 10, 3010 (2019).","journal-title":"Front Immunol."},{"key":"55934_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fcimb.2020.00049","volume":"10","author":"SJ Judge","year":"2020","unstructured":"Judge, S. J., Murphy, W. J. & Canter, R. J. Characterizing the dysfunctional NK cell: assessing the clinical relevance of exhaustion, anergy, and senescence. Front Cell Infect. Microbiol. 10, 49 (2020).","journal-title":"Front Cell Infect. Microbiol."},{"key":"55934_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633\u2013643 (2013).","journal-title":"Immunity"},{"key":"55934_CR28","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.4049\/jimmunol.0903002","volume":"184","author":"DJ Kominsky","year":"2010","unstructured":"Kominsky, D. J., Campbell, E. L. & Colgan, S. P. Metabolic shifts in immunity and inflammation. J. Immunol. 184, 4062\u20134068 (2010).","journal-title":"J. Immunol."},{"key":"55934_CR29","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3389\/fimmu.2019.01414","volume":"10","author":"SM Poznanski","year":"2019","unstructured":"Poznanski, S. M. & Ashkar, A. A. What defines NK cell functional fate: phenotype or metabolism? Front Immunol. 10, 1414 (2019).","journal-title":"Front Immunol."},{"key":"55934_CR30","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3389\/fimmu.2020.01989","volume":"11","author":"J Cong","year":"2020","unstructured":"Cong, J. Metabolism of natural killer cells and other innate lymphoid cells. Front Immunol. 11, 1989 (2020).","journal-title":"Front Immunol."},{"key":"55934_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","volume":"9","author":"V Chiurchiu","year":"2018","unstructured":"Chiurchiu, V., Leuti, A. & Maccarrone, M. Bioactive lipids and chronic inflammation: managing the fire within. Front Immunol. 9, 38 (2018).","journal-title":"Front Immunol."},{"key":"55934_CR32","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1097\/MD.0000000000001528","volume":"94","author":"G Annicchiarico","year":"2015","unstructured":"Annicchiarico, G. et al. Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa. Med. (Baltim.) 94, e1528 (2015).","journal-title":"Med. (Baltim.)"},{"key":"55934_CR33","doi-asserted-by":"crossref","unstructured":"Reimer-Taschenbrecker, A. et al. IL-6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: a prospective cohort study. J. Eur. Acad. Dermatol. Venereol. 39, 202-209 (2024).","DOI":"10.1111\/jdv.19898"},{"key":"55934_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677008","volume":"12","author":"H Islam","year":"2021","unstructured":"Islam, H., Chamberlain, T. C., Mui, A. L. & Little, J. P. Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action? Front Immunol. 12, 677008 (2021).","journal-title":"Front Immunol."},{"key":"55934_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.110805","volume":"85","author":"C Santucci","year":"2024","unstructured":"Santucci, C. et al. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Hum. Immunol. 85, 110805 (2024).","journal-title":"Hum. Immunol."},{"key":"55934_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15146","volume":"33","author":"L Quintana-Castanedo","year":"2024","unstructured":"Quintana-Castanedo, L. et al. Unveiling the value of C-reactive protein as a severity biomarker and the IL4\/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: a multiparametric cross-sectional study. Exp. Dermatol 33, e15146 (2024).","journal-title":"Exp. Dermatol"},{"key":"55934_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114864","volume":"13","author":"CL Ebens","year":"2021","unstructured":"Ebens, C. L. Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa. EMBO Mol. Med. 13, e14864 (2021).","journal-title":"EMBO Mol. Med."},{"key":"55934_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/eji.201948362","volume":"50","author":"L Pangrazzi","year":"2020","unstructured":"Pangrazzi, L. et al. CD28 and CD57 define four populations with distinct phenotypic properties within human CD8(+) T cells. Eur. J. Immunol. 50, 363\u2013379 (2020).","journal-title":"Eur. J. Immunol."},{"key":"55934_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638010","volume":"12","author":"CL Shive","year":"2021","unstructured":"Shive, C. L. et al. Markers of T cell exhaustion and senescence and their relationship to plasma TGF-beta levels in treated HIV+ immune non-responders. Front Immunol. 12, 638010 (2021).","journal-title":"Front Immunol."},{"key":"55934_CR40","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/14397595.2019.1667473","volume":"30","author":"J Leipe","year":"2020","unstructured":"Leipe, J., Pirronello, F., Klose, A., Schulze-Koops, H. & Skapenko, A. Increased plasticity of non-classic Th1 cells toward the Th17 phenotype. Mod. Rheumatol. 30, 930\u2013936 (2020).","journal-title":"Mod. Rheumatol."},{"key":"55934_CR41","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C. et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).","journal-title":"Science"},{"key":"55934_CR42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202191","volume":"218","author":"R Bechara","year":"2021","unstructured":"Bechara, R., McGeachy, M. J. & Gaffen, S. L. The metabolism-modulating activity of IL-17 signaling in health and disease. J. Exp. Med. 218, e20202191 (2021).","journal-title":"J. Exp. Med."},{"key":"55934_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150079","volume":"7","author":"JA Myers","year":"2022","unstructured":"Myers, J. A. et al. Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion. JCI Insight 7, e150079 (2022).","journal-title":"JCI Insight"},{"key":"55934_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09212-y","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nat. Commun. 10, 1507 (2019).","journal-title":"Nat. Commun."},{"key":"55934_CR45","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1172\/JCI138554","volume":"130","author":"A Mazzoni","year":"2020","unstructured":"Mazzoni, A. et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J. Clin. Invest. 130, 4694\u20134703 (2020).","journal-title":"J. Clin. Invest."},{"key":"55934_CR46","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/1523-1747.ep12471769","volume":"89","author":"SC Cunnane","year":"1987","unstructured":"Cunnane, S. C. et al. Abnormalities of plasma and erythrocyte essential fatty acid composition in epidermolysis bullosa: influence of treatment with diphenylhydantoin. J. Invest. Dermatol. 89, 395\u2013399 (1987).","journal-title":"J. Invest. Dermatol."},{"key":"55934_CR47","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1056\/NEJM198505093121903","volume":"312","author":"TH Lee","year":"1985","unstructured":"Lee, T. H. et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 312, 1217\u20131224 (1985).","journal-title":"N. Engl. J. Med."},{"key":"55934_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang, B. et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct. Target Ther. 6, 94 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"55934_CR49","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCRESAHA.121.320548","volume":"130","author":"K Ma","year":"2022","unstructured":"Ma, K. et al. Therapeutic and prognostic significance of arachidonic acid in heart failure. Circ. Res. 130, 1056\u20131071 (2022).","journal-title":"Circ. Res."},{"key":"55934_CR50","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jaci.2021.02.041","volume":"148","author":"YA Rodriguez-Rosales","year":"2021","unstructured":"Rodriguez-Rosales, Y. A. et al. Immunomodulatory aged neutrophils are augmented in blood and skin of psoriasis patients. J. Allergy Clin. Immunol. 148, 1030\u20131040 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"55934_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.621222","volume":"11","author":"PPG Mulder","year":"2020","unstructured":"Mulder, P. P. G. et al. Persistent systemic inflammation in patients with severe burn injury is accompanied by influx of immature neutrophils and shifts in T cell subsets and cytokine profiles. Front Immunol. 11, 621222 (2020).","journal-title":"Front Immunol."},{"key":"55934_CR52","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3389\/fimmu.2019.01671","volume":"10","author":"S Gomez-Olarte","year":"2019","unstructured":"Gomez-Olarte, S. et al. Intermediate monocytes and cytokine production associated with severe forms of chagas disease. Front Immunol. 10, 1671 (2019).","journal-title":"Front Immunol."},{"key":"55934_CR53","doi-asserted-by":"crossref","unstructured":"Veenhuis, R. T. et al. Higher circulating intermediate monocytes are associated with cognitive function in women with HIV. JCI Insight. 6, e146215 (2021).","DOI":"10.1172\/jci.insight.146215"},{"key":"55934_CR54","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/BF02331385","volume":"28","author":"I Virtanen","year":"1996","unstructured":"Virtanen, I. et al. Laminin chains in the basement membranes of human thymus. Histochem J. 28, 643\u2013650 (1996).","journal-title":"Histochem J."},{"key":"55934_CR55","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.3390\/ijms20225707","volume":"20","author":"AG Condorelli","year":"2019","unstructured":"Condorelli, A. G., Dellambra, E., Logli, E., Zambruno, G. & Castiglia, D. Epidermolysis bullosa-associated squamous cell carcinoma: from pathogenesis to therapeutic perspectives. Int J. Mol. Sci. 20, 5707 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"55934_CR56","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/bjd.18475","volume":"182","author":"A Reimer","year":"2020","unstructured":"Reimer, A. et al. Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study. Br. J. Dermatol. 182, 1437\u20131448 (2020).","journal-title":"Br. J. Dermatol."},{"key":"55934_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCRESAHA.112.276501","volume":"112","author":"L Lauden","year":"2013","unstructured":"Lauden, L. et al. Allogenicity of human cardiac stem\/progenitor cells orchestrated by programmed death ligand 1. Circ. Res. 112, 451\u2013464 (2013).","journal-title":"Circ. Res."},{"key":"55934_CR58","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.3389\/fimmu.2018.03121","volume":"9","author":"R Al-Daccak","year":"2018","unstructured":"Al-Daccak, R. & Charron, D. Editorial: Alloimmune response from regenerative medicine. Front Immunol. 9, 3121 (2018).","journal-title":"Front Immunol."},{"key":"55934_CR59","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41590-019-0356-7","volume":"20","author":"N Giannakis","year":"2019","unstructured":"Giannakis, N. et al. Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration. Nat. Immunol. 20, 626\u2013636 (2019).","journal-title":"Nat. Immunol."},{"key":"55934_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/sctm.18-0256","volume":"8","author":"HR Hocine","year":"2019","unstructured":"Hocine, H. R. et al. Extracellular vesicles released by Allogeneic human cardiac stem\/progenitor cells as part of their therapeutic benefit. Stem Cells Transl. Med. 8, 911\u2013924 (2019).","journal-title":"Stem Cells Transl. Med."},{"key":"55934_CR61","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/cvr\/cvaa028","volume":"117","author":"B Lima Correa","year":"2021","unstructured":"Lima Correa, B. et al. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts. Cardiovasc Res. 117, 292\u2013307 (2021).","journal-title":"Cardiovasc Res."},{"key":"55934_CR62","doi-asserted-by":"crossref","unstructured":"Manchon E., Hirt N., Bouaziz J. D., Jabrane-Ferrat N., Al-Daccak R. Stem cells-derived extracellular vesicles: potential therapeutics for wound healing in chronic inflammatory skin diseases. Int. J. Mol. Sci. 22, 3130 (2021).","DOI":"10.3390\/ijms22063130"},{"key":"55934_CR63","doi-asserted-by":"crossref","unstructured":"Eichstadt S. et al. Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight 4, e130554 (2019).","DOI":"10.1172\/jci.insight.130554"},{"key":"55934_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","volume":"28","author":"I Gurevich","year":"2022","unstructured":"Gurevich, I. et al. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial. Nat. Med. 28, 780\u2013788 (2022).","journal-title":"Nat. Med."},{"key":"55934_CR65","first-page":"1689","volume":"53","author":"E Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 53, 1689\u20131699 (2018).","journal-title":"Nat. Biotechnol."},{"key":"55934_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","volume":"11","author":"C Giesen","year":"2014","unstructured":"Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417\u2013422 (2014).","journal-title":"Nat. Methods"},{"key":"55934_CR67","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","volume":"32","author":"RJ Arguello","year":"2020","unstructured":"Arguello, R. J. et al. SCENITH: A flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, 1063\u20131075.e1067 (2020).","journal-title":"Cell Metab."},{"key":"55934_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1072118","volume":"14","author":"Y Scuiller","year":"2023","unstructured":"Scuiller, Y. et al. YOUPI: Your powerful and intelligent tool for segmenting cells from imaging mass cytometry data. Front Immunol. 14, 1072118 (2023).","journal-title":"Front Immunol."},{"key":"55934_CR69","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/cvr\/cvu208","volume":"104","author":"W Boukouaci","year":"2014","unstructured":"Boukouaci, W. et al. Natural killer cell crosstalk with allogeneic human cardiac-derived stem\/progenitor cells controls persistence. Cardiovasc Res 104, 290\u2013302 (2014).","journal-title":"Cardiovasc Res"},{"key":"55934_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16754-z","volume":"11","author":"Q Chen","year":"2020","unstructured":"Chen, Q. et al. Metabolic reprogramming by Zika virus provokes inflammation in human placenta. Nat. Commun. 11, 2967 (2020).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55934-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:10:59Z","timestamp":1736899859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55934-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55934"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-55934-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}